Nature Metrics Limited - Period Ending 2022-12-31

Nature Metrics Limited - Period Ending 2022-12-31


Nature Metrics Limited 09243907 false 2022-01-01 2022-12-31 2022-12-31 2022-12-31 The principal activity of the company is environmental consulting, biotechnology research and development. Digita Accounts Production Advanced 6.30.9574.0 true true true false true false false 09243907 2022-01-01 2022-12-31 09243907 2022-12-31 09243907 bus:Director2 bus:Consolidated 2022-12-31 09243907 bus:Director4 bus:Consolidated 2022-12-31 09243907 bus:Director5 bus:Consolidated 2022-12-31 09243907 bus:Director6 bus:Consolidated 2022-12-31 09243907 bus:Director7 bus:Consolidated 2022-12-31 09243907 bus:Director8 bus:Consolidated 2022-12-31 09243907 bus:Director9 bus:Consolidated 2022-12-31 09243907 bus:OrdinaryShareClass1 bus:Consolidated 2022-12-31 09243907 bus:OrdinaryShareClass2 bus:Consolidated 2022-12-31 09243907 bus:OrdinaryShareClass3 bus:Consolidated 2022-12-31 09243907 bus:Consolidated 2022-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity 2022-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity bus:Consolidated 2022-12-31 09243907 core:RetainedEarningsAccumulatedLosses 2022-12-31 09243907 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2022-12-31 09243907 core:ShareCapital 2022-12-31 09243907 core:ShareCapital bus:Consolidated 2022-12-31 09243907 core:SharePremium 2022-12-31 09243907 core:SharePremium bus:Consolidated 2022-12-31 09243907 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2022-12-31 09243907 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments 2022-12-31 09243907 core:FinancialAssetsCostLessImpairment core:Non-currentFinancialInstruments bus:Consolidated 2022-12-31 09243907 core:CurrentFinancialInstruments 2022-12-31 09243907 core:CurrentFinancialInstruments bus:Consolidated 2022-12-31 09243907 core:CurrentFinancialInstruments bus:Consolidated 1 2022-12-31 09243907 core:CurrentFinancialInstruments bus:Consolidated 2 2022-12-31 09243907 core:CurrentFinancialInstruments 1 2022-12-31 09243907 core:CurrentFinancialInstruments 2 2022-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear 2022-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2022-12-31 09243907 core:Non-currentFinancialInstruments 2022-12-31 09243907 core:Non-currentFinancialInstruments bus:Consolidated 2022-12-31 09243907 core:Non-currentFinancialInstruments core:AfterOneYear 2022-12-31 09243907 core:Non-currentFinancialInstruments core:AfterOneYear bus:Consolidated 2022-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar 2022-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar bus:Consolidated 2022-12-31 09243907 core:AdditionsToInvestments 2022-12-31 09243907 core:FurnitureFittingsToolsEquipment 2022-12-31 09243907 core:FurnitureFittingsToolsEquipment bus:Consolidated 2022-12-31 09243907 core:OtherPropertyPlantEquipment 2022-12-31 09243907 core:OtherPropertyPlantEquipment bus:Consolidated 2022-12-31 09243907 bus:FRS102 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Audited bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:FullAccounts bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:RegisteredOffice bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Director1 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Director2 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Director3 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Director4 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Director5 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Director6 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Director7 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Director8 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Director9 2022-01-01 2022-12-31 09243907 bus:Director9 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:OrdinaryShareClass1 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:OrdinaryShareClass2 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:OrdinaryShareClass3 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:Consolidated 1 2022-01-01 2022-12-31 09243907 bus:Consolidated 1 2022-01-01 2022-12-31 09243907 bus:Consolidated 2 2022-01-01 2022-12-31 09243907 bus:PrivateLimitedCompanyLtd bus:Consolidated 2022-01-01 2022-12-31 09243907 bus:ConsolidatedGroupCompanyAccounts 2022-01-01 2022-12-31 09243907 1 2022-01-01 2022-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity 2022-01-01 2022-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity bus:Consolidated 2022-01-01 2022-12-31 09243907 core:RetainedEarningsAccumulatedLosses 2022-01-01 2022-12-31 09243907 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2022-01-01 2022-12-31 09243907 core:ShareCapital 2022-01-01 2022-12-31 09243907 core:ShareCapital bus:Consolidated 2022-01-01 2022-12-31 09243907 core:SharePremium 2022-01-01 2022-12-31 09243907 core:SharePremium bus:Consolidated 2022-01-01 2022-12-31 09243907 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2022-01-01 2022-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar 2022-01-01 2022-12-31 09243907 core:PatentsTrademarksLicencesConcessionsSimilar bus:Consolidated 2022-01-01 2022-12-31 09243907 core:FurnitureFittings bus:Consolidated 2022-01-01 2022-12-31 09243907 core:FurnitureFittingsToolsEquipment 2022-01-01 2022-12-31 09243907 core:FurnitureFittingsToolsEquipment bus:Consolidated 2022-01-01 2022-12-31 09243907 core:OtherPropertyPlantEquipment 2022-01-01 2022-12-31 09243907 core:OtherPropertyPlantEquipment bus:Consolidated 2022-01-01 2022-12-31 09243907 core:Subsidiary1 2022-01-01 2022-12-31 09243907 core:Subsidiary1 1 2022-01-01 2022-12-31 09243907 core:Subsidiary1 countries:Canada 2022-01-01 2022-12-31 09243907 core:UKTax bus:Consolidated 2022-01-01 2022-12-31 09243907 countries:EnglandWales bus:Consolidated 2022-01-01 2022-12-31 09243907 2021-12-31 09243907 bus:Consolidated 2021-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity 2021-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity bus:Consolidated 2021-12-31 09243907 core:RetainedEarningsAccumulatedLosses 2021-12-31 09243907 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2021-12-31 09243907 core:ShareCapital 2021-12-31 09243907 core:ShareCapital bus:Consolidated 2021-12-31 09243907 core:SharePremium 2021-12-31 09243907 core:SharePremium bus:Consolidated 2021-12-31 09243907 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2021-12-31 09243907 core:FurnitureFittingsToolsEquipment 2021-12-31 09243907 core:FurnitureFittingsToolsEquipment bus:Consolidated 2021-12-31 09243907 core:OtherPropertyPlantEquipment 2021-12-31 09243907 core:OtherPropertyPlantEquipment bus:Consolidated 2021-12-31 09243907 2021-01-01 2021-12-31 09243907 2021-12-31 09243907 bus:OrdinaryShareClass1 bus:Consolidated 2021-12-31 09243907 bus:OrdinaryShareClass2 bus:Consolidated 2021-12-31 09243907 bus:OrdinaryShareClass3 bus:Consolidated 2021-12-31 09243907 bus:Consolidated 2021-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity 2021-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity bus:Consolidated 2021-12-31 09243907 core:RetainedEarningsAccumulatedLosses 2021-12-31 09243907 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2021-12-31 09243907 core:ShareCapital 2021-12-31 09243907 core:ShareCapital bus:Consolidated 2021-12-31 09243907 core:SharePremium 2021-12-31 09243907 core:SharePremium bus:Consolidated 2021-12-31 09243907 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2021-12-31 09243907 core:CurrentFinancialInstruments 2021-12-31 09243907 core:CurrentFinancialInstruments bus:Consolidated 2021-12-31 09243907 core:CurrentFinancialInstruments bus:Consolidated 1 2021-12-31 09243907 core:CurrentFinancialInstruments bus:Consolidated 2 2021-12-31 09243907 core:CurrentFinancialInstruments 1 2021-12-31 09243907 core:CurrentFinancialInstruments 2 2021-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear 2021-12-31 09243907 core:CurrentFinancialInstruments core:WithinOneYear bus:Consolidated 2021-12-31 09243907 core:Non-currentFinancialInstruments 2021-12-31 09243907 core:Non-currentFinancialInstruments bus:Consolidated 2021-12-31 09243907 core:Non-currentFinancialInstruments core:AfterOneYear 2021-12-31 09243907 core:Non-currentFinancialInstruments core:AfterOneYear bus:Consolidated 2021-12-31 09243907 core:FurnitureFittingsToolsEquipment 2021-12-31 09243907 core:FurnitureFittingsToolsEquipment bus:Consolidated 2021-12-31 09243907 core:OtherPropertyPlantEquipment 2021-12-31 09243907 core:OtherPropertyPlantEquipment bus:Consolidated 2021-12-31 09243907 bus:OrdinaryShareClass3 bus:Consolidated 2021-01-01 2021-12-31 09243907 bus:Consolidated 2021-01-01 2021-12-31 09243907 bus:Consolidated 1 2021-01-01 2021-12-31 09243907 1 2021-01-01 2021-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity 2021-01-01 2021-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity bus:Consolidated 2021-01-01 2021-12-31 09243907 core:RetainedEarningsAccumulatedLosses 2021-01-01 2021-12-31 09243907 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2021-01-01 2021-12-31 09243907 core:ShareCapital 2021-01-01 2021-12-31 09243907 core:ShareCapital bus:Consolidated 2021-01-01 2021-12-31 09243907 core:SharePremium 2021-01-01 2021-12-31 09243907 core:SharePremium bus:Consolidated 2021-01-01 2021-12-31 09243907 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2021-01-01 2021-12-31 09243907 core:Subsidiary1 1 2021-01-01 2021-12-31 09243907 core:UKTax bus:Consolidated 2021-01-01 2021-12-31 09243907 2020-12-31 09243907 bus:Consolidated 2020-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity 2020-12-31 09243907 core:FurtherSpecificReserve1ComponentTotalEquity bus:Consolidated 2020-12-31 09243907 core:RetainedEarningsAccumulatedLosses 2020-12-31 09243907 core:RetainedEarningsAccumulatedLosses bus:Consolidated 2020-12-31 09243907 core:ShareCapital 2020-12-31 09243907 core:ShareCapital bus:Consolidated 2020-12-31 09243907 core:SharePremium 2020-12-31 09243907 core:SharePremium bus:Consolidated 2020-12-31 09243907 core:TotalEquityAttributableToOwnersParentBeforeNon-controllingInterests bus:Consolidated 2020-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 09243907

Nature Metrics Limited

Annual Report and Consolidated Financial Statements

for the Year Ended 31 December 2022

 

Nature Metrics Limited

Contents

Company Information

1

Strategic Report

2

Directors' Report

3

Statement of Directors' Responsibilities

4

Independent Auditor's Report

5 to 7

Consolidated Profit and Loss Account

8

Consolidated Statement of Comprehensive Income

9

Consolidated Balance Sheet

10

Balance Sheet

11

Consolidated Statement of Changes in Equity

12

Statement of Changes in Equity

13

Consolidated Statement of Cash Flows

14

Statement of Cash Flows

15

Notes to the Financial Statements

16 to 29

 

Nature Metrics Limited

Company Information

Directors

Dr C Bruce

Mr R Ellis

Mr J Schrieber

Mr N C Von Luttichau Jolck

Mr I Davies

Registered office

1 Occam Court
Surrey Research Park
Guildford
Surrey
GU2 7HJ

Auditors

Metric Accountants Limited
2nd Floor
20 St Thomas Street
London
SE1 9RS

 

Nature Metrics Limited

Strategic Report for the Year Ended 31 December 2022

The directors present their strategic report for the year ended 31 December 2022.

Principal activity

The principal activity of the group is environmental consulting, biotechnology research and development.

Fair review of the business

The Group results for the year were:
Operating loss of £7,818,780 (2021: £3,433,686)
Loss before taxation of £7,885,621 (2021: £3,442,814)
Net cash increase of £2,797,894 (2021: £2,601,476)

The Company results for the year were:
Operating loss of £7,102,978 (2021: £3,433,686)
Loss before taxation of £7,205,754 (2021: £3,442,814)
Net cash increase of £2,729,233 (2021: £2,601,476)

During the year the company received proceeds of £11,835,324 from the issue of ordinary shares.
On 1 February 2022 a 100% subsidiary, Nature Metrics North America Ltd, was incorporated in Canada.

Note that all comparatives do not include the performance of the newly incorporated subsidiary.

In arriving at these results the Board has made careful consideration of processes surrounding the business, in particular cashflow management to maximise financial performance.

As at 31 December 2022, the Group net cash balance was £6,540,255 (2021: £3,742,361).
As at 31 December 2022, the company net cash balance was £6,471,594 (2021: £3,742,361).

The Directors use a range of KPIs and other metrics to measure performance of the business.

Principal risks and uncertainties

One of the key risks facing the groups activities is the general economic climate as a result of inflationary pressures of the economy. While this inflationary pressure is particularly central on fuel and food, it leads to general uncertainty and caution. To date, the group has not been adversely affected in demand for its products and services.

Another key risk facing the group remains the general economic climate as a result of the coronavirus pandemic. The impact of the group's trade has been minimal from its experience. While it may not affect the group's industry directly, it has a significant impact on the general economy and the impacts can follow through to the group.

The group holds no publicly held investments and as such it is not exposed to the risk these factors pose to the stock market.

Approved by the Board on 29 September 2023 and signed on its behalf by:

.........................................
Mr I Davies
Director

   
     
 

Nature Metrics Limited

Directors' Report for the Year Ended 31 December 2022

The directors present their report and the for the year ended 31 December 2022.

Directors of the group

The directors who held office during the year were as follows:

Dr C Bruce

Ms K Critchlow (ceased 27 July 2023)

Mr R Ellis

Mr J Schrieber (appointed 1 September 2022)

Mr N C Von Luttichau Jolck (appointed 18 May 2022)

Mr S Acland (ceased 18 May 2022)

Mr A Barron (ceased 1 September 2022)

Dr J Jones (ceased 18 May 2022)

The following director was appointed after the year end:

Mr I Davies (appointed 27 July 2023)

Going concern

During the year the Group made losses of £4,668,472 and management forecast that the Group will continue to be loss making in the short term future. However, as at 31 Dec 2022 the Group had a cash balance of £6,540,255 and post year end raised a further £9,499,997. Due to the current net asset position as at 31 December 2022 and the strong cash balance following the successful fundraise in 2023, the Board are confident that the Company will be able to meet its liabilities as they fall due for a period of not less than 12 months from the signing of the Balance Sheet.

On this understanding, the financial statements have been prepared on a going concern basis.

Disclosure of information to the auditor

Each director has taken steps that they ought to have taken as a director in order to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information. The directors confirm that there is no relevant information that they know of and of which they know the auditor is unaware.

Approved by the Board on 29 September 2023 and signed on its behalf by:

.........................................
Mr I Davies
Director

   
     
 

Nature Metrics Limited

Statement of Directors' Responsibilities

The directors acknowledge their responsibilities for preparing the Annual Report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and the company and of the profit or loss of the group for that period. In preparing these financial statements, the directors are required to:

select suitable accounting policies and apply them consistently;

make judgements and accounting estimates that are reasonable and prudent;

state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group's and the company's transactions and disclose with reasonable accuracy at any time the financial position of the group and the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

 

Nature Metrics Limited

Independent Auditor's Report to the Members of Nature Metrics Limited

Opinion

We have audited the financial statements of Nature Metrics Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 December 2022, which comprise the Consolidated Profit and Loss Account, Consolidated Statement of Comprehensive Income, Consolidated Balance Sheet, Balance Sheet, Consolidated Statement of Changes in Equity, Statement of Changes in Equity, Consolidated Statement of Cash Flows, Statement of Cash Flows, and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the group's and the parent company's affairs as at 31 December 2022 and of the group's loss for the year then ended;

have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor responsibilities for the audit of the financial statements section of our report. We are independent of the group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's ability to continue as a going concern for a period of at least twelve months from when the original financial statements were authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

 

Nature Metrics Limited

Independent Auditor's Report to the Members of Nature Metrics Limited

Opinion on other matter prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the Strategic Report and Directors' Report for the financial year for which the financial statements are prepared is consistent with the financial statements; and

the Strategic Report and Directors' Report have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report and the Directors' Report.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or

the parent company financial statements are not in agreement with the accounting records and returns; or

certain disclosures of directors' remuneration specified by law are not made; or

we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities [set out on page 4], the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor Responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

 

Nature Metrics Limited

Independent Auditor's Report to the Members of Nature Metrics Limited

As part of designing our audit, we determined materiality and assessed the risks of material misstatement in the financial statements, including how fraud may occur by enquiring of management of its own consideration of fraud. In particular, we looked at where management made subjective judgements, for example in respect of significant accounting estimates that involved making assumptions and considering future events that are inherently uncertain.

Appropriate procedures included the review and testing of manual journals and key estimates and judgements made by management.

We gained an understanding of the legal and regulatory framework applicable to the Company and the industry in which it operates, drawing on our broad sector experience, and considered the risk of acts by the Company that were contrary to these laws and regulations, including fraud. We focused on laws and regulations that could give rise to a material misstatement in the financial statements, including the Companies Act 2006 and UK tax legislation.

We made enquiries of management with regards to compliance with the above laws and regulations and corroborated any necessary evidence to relevant information, for example, minutes of meetings and correspondence, including legal correspondence.

Our tests included agreeing the financial statements disclosures to underlying supporting documentation and enquiries with management.

Our audit procedures were designed to respond to risks of material misstatement in the financial statements, recognising that the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery, misrepresentations or through collusion.

There are inherent limitations in the audit procedures performed and the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we are to become aware of it.

A further description of our responsibilities is available on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

......................................
James Richardson (Senior Statutory Auditor)
For and on behalf of Metric Accountants Limited, Statutory Auditor

2nd Floor
20 St Thomas Street
London
SE1 9RS

29 September 2023

 

Nature Metrics Limited

Consolidated Profit and Loss Account for the Year Ended 31 December 2022

Note

2022
£

2021
£

Turnover

3

4,118,376

2,183,679

Cost of sales

 

(2,928,508)

(990,026)

Gross profit

 

1,189,868

1,193,653

Administrative expenses

 

(9,008,738)

(4,637,797)

Other operating income

4

-

10,458

Operating loss

5

(7,818,870)

(3,433,686)

Income from other Fixed assets investments

 

(33,224)

-

Other interest receivable and similar income

6

2,534

-

Interest payable and similar expenses

7

(36,061)

(9,128)

   

(66,751)

(9,128)

Loss before tax

 

(7,885,621)

(3,442,814)

Tax on loss

11

337,610

194,831

Loss for the financial year

 

(7,548,011)

(3,247,983)

Profit/(loss) attributable to:

 

Owners of the company

 

(7,548,011)

(3,247,983)

The group has no recognised gains or losses for the year other than the results above.

 

Nature Metrics Limited

Consolidated Statement of Comprehensive Income for the Year Ended 31 December 2022

2022
£

2021
£

Loss for the year

(7,548,011)

(3,247,983)

Total comprehensive income for the year

(7,548,011)

(3,247,983)

Total comprehensive income attributable to:

Owners of the company

(7,548,011)

(3,247,983)

 

Nature Metrics Limited

(Registration number: 09243907)
Consolidated Balance Sheet as at 31 December 2022

Note

2022
£

2021
£

Fixed assets

 

Intangible assets

12

65,901

-

Tangible assets

13

2,847,621

1,481,126

Other financial assets

15

186,138

219,362

 

3,099,660

1,700,488

Current assets

 

Stocks

16

428,084

336,650

Debtors

17

2,159,713

1,488,315

Cash at bank and in hand

 

6,540,255

3,742,361

 

9,128,052

5,567,326

Creditors: Amounts falling due within one year

19

(2,847,113)

(2,124,671)

Net current assets

 

6,280,939

3,442,655

Total assets less current liabilities

 

9,380,599

5,143,143

Creditors: Amounts falling due after more than one year

19

(7,310)

(51,173)

Provisions for liabilities

-

(10,004)

Net assets

 

9,373,289

5,081,966

Capital and reserves

 

Called up share capital

22

5

4

Share premium reserve

21,055,538

9,220,215

Other reserves

37,129

33,119

Retained earnings

(11,719,383)

(4,171,372)

Equity attributable to owners of the company

 

9,373,289

5,081,966

Shareholders' funds

 

9,373,289

5,081,966

Approved and authorised by the Board on 29 September 2023 and signed on its behalf by:
 

.........................................
Mr I Davies
Director

 

Nature Metrics Limited

(Registration number: 09243907)
Balance Sheet as at 31 December 2022

Note

2022
£

2021
£

Fixed assets

 

Intangible assets

12

65,901

-

Tangible assets

13

1,734,129

1,481,126

Investments

14

1

-

Other financial assets

15

186,138

219,362

 

1,986,169

1,700,488

Current assets

 

Stocks

16

397,264

336,650

Debtors

17

3,882,340

1,488,315

Cash at bank and in hand

 

6,471,594

3,742,361

 

10,751,198

5,567,326

Creditors: Amounts falling due within one year

19

(2,676,901)

(2,124,671)

Net current assets

 

8,074,297

3,442,655

Total assets less current liabilities

 

10,060,466

5,143,143

Creditors: Amounts falling due after more than one year

19

(7,310)

(51,173)

Provisions for liabilities

-

(10,004)

Net assets

 

10,053,156

5,081,966

Capital and reserves

 

Called up share capital

22

5

4

Share premium reserve

21,055,538

9,220,215

Other reserves

37,129

33,119

Retained earnings

(11,039,516)

(4,171,372)

Shareholders' funds

 

10,053,156

5,081,966

The company made a loss after tax for the financial year of £6,868,144 (2021 - loss of £3,247,983).

Approved and authorised by the Board on 29 September 2023 and signed on its behalf by:
 

.........................................
Mr I Davies
Director

   
     
 

Nature Metrics Limited

Consolidated Statement of Changes in Equity for the Year Ended 31 December 2022
Equity attributable to the parent company

Share capital
£

Share premium
£

Other reserves
£

Retained earnings
£

Total
£

Total equity
£

At 1 January 2022

4

9,220,215

33,119

(4,171,372)

5,081,966

5,081,966

Loss for the year

-

-

-

(7,548,011)

(7,548,011)

(7,548,011)

New share capital subscribed

1

11,835,323

-

-

11,835,324

11,835,324

Other movements on reserves

-

-

4,010

-

4,010

4,010

At 31 December 2022

5

21,055,538

37,129

(11,719,383)

9,373,289

9,373,289

Share capital
£

Share premium
£

Other reserves
£

Retained earnings
£

Total
£

Total equity
£

At 1 January 2021

2

2,720,219

-

(923,389)

1,796,832

1,796,832

Loss for the year

-

-

-

(3,247,983)

(3,247,983)

(3,247,983)

New share capital subscribed

2

6,499,996

-

-

6,499,998

6,499,998

Other movements on reserves

-

-

33,119

-

33,119

33,119

At 31 December 2021

4

9,220,215

33,119

(4,171,372)

5,081,966

5,081,966

 

Nature Metrics Limited

Statement of Changes in Equity for the Year Ended 31 December 2022

Share capital
£

Share premium
£

Other reserves
£

Retained earnings
£

Total
£

At 1 January 2022

4

9,220,215

33,119

(4,171,372)

5,081,966

Loss for the year

-

-

-

(6,868,144)

(6,868,144)

New share capital subscribed

1

11,835,323

-

-

11,835,324

Other movements on reserves

-

-

4,010

-

4,010

At 31 December 2022

5

21,055,538

37,129

(11,039,516)

10,053,156

Share capital
£

Share premium
£

Other reserves
£

Retained earnings
£

Total
£

At 1 January 2021

2

2,720,219

-

(923,389)

1,796,832

Loss for the year

-

-

-

(3,247,983)

(3,247,983)

New share capital subscribed

2

6,499,996

-

-

6,499,998

Other movements on reserves

-

-

33,119

-

33,119

At 31 December 2021

4

9,220,215

33,119

(4,171,372)

5,081,966

 

Nature Metrics Limited

Consolidated Statement of Cash Flows for the Year Ended 31 December 2022

Note

2022
£

2021
£

Cash flows from operating activities

Loss for the year

 

(7,548,011)

(3,247,983)

Adjustments to cash flows from non-cash items

 

Depreciation and amortisation

5

732,423

142,012

Changes in fair value of investments

33,224

-

Finance income

6

(2,534)

-

Finance costs

7

65,023

8,731

Share based payment transactions

 

4,010

33,119

Income tax expense

11

(337,610)

(194,831)

 

(7,053,475)

(3,258,952)

Working capital adjustments

 

Increase in stocks

16

(91,434)

(214,277)

Increase in trade debtors

17

(339,800)

(1,009,343)

Increase in trade creditors

19

513,064

1,339,342

Increase in deferred income, including government grants

 

209,378

605,753

Cash generated from operations

 

(6,762,267)

(2,537,477)

Income taxes (paid)/received

11

(3,993)

87,562

Net cash flow from operating activities

 

(6,766,260)

(2,449,915)

Cash flows from investing activities

 

Interest received

2,534

-

Acquisitions of tangible assets

(2,094,018)

(1,534,911)

Acquisition of intangible assets

12

(70,801)

-

Net cash flows from investing activities

 

(2,162,285)

(1,534,911)

Cash flows from financing activities

 

Interest paid

7

(65,023)

(8,731)

Proceeds from issue of ordinary shares, net of issue costs

 

11,835,325

6,499,998

Proceeds from bank borrowing draw downs

 

(43,863)

95,035

Net cash flows from financing activities

 

11,726,439

6,586,302

Net increase in cash and cash equivalents

 

2,797,894

2,601,476

Cash and cash equivalents at 1 January

 

3,742,361

1,140,885

Cash and cash equivalents at 31 December

 

6,540,255

3,742,361

 

Nature Metrics Limited

Statement of Cash Flows for the Year Ended 31 December 2022

Note

2022
£

2021
£

Cash flows from operating activities

Loss for the year

 

(6,868,144)

(3,247,983)

Adjustments to cash flows from non-cash items

 

Depreciation and amortisation

5

449,969

142,012

Changes in fair value of investments

33,224

-

Finance income

(2,534)

-

Finance costs

65,019

8,731

Share based payment transactions

 

4,010

33,119

Income tax expense

11

(337,610)

(194,831)

 

(6,656,066)

(3,258,952)

Working capital adjustments

 

Increase in stocks

16

(60,614)

(214,277)

Increase in trade debtors

17

(2,062,427)

(1,009,343)

Increase in trade creditors

19

437,173

1,339,342

Increase in deferred income, including government grants

 

115,057

605,753

Cash generated from operations

 

(8,226,877)

(2,537,477)

Income taxes (paid)/received

11

(3,993)

87,562

Net cash flow from operating activities

 

(8,230,870)

(2,449,915)

Cash flows from investing activities

 

Interest received

2,534

-

Acquisition of subsidiaries

14

(1)

-

Acquisitions of tangible assets

(698,072)

(1,534,911)

Acquisition of intangible assets

12

(70,801)

-

Net cash flows from investing activities

 

(766,340)

(1,534,911)

Cash flows from financing activities

 

Interest paid

(65,019)

(8,731)

Proceeds from issue of ordinary shares, net of issue costs

 

11,835,325

6,499,998

Proceeds from bank borrowing draw downs

 

(43,863)

95,035

Net cash flows from financing activities

 

11,726,443

6,586,302

Net increase in cash and cash equivalents

 

2,729,233

2,601,476

Cash and cash equivalents at 1 January

 

3,742,361

1,140,885

Cash and cash equivalents at 31 December

 

6,471,594

3,742,361

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
1 Occam Court
Surrey Research Park
Guildford
Surrey
GU2 7HJ

These financial statements were authorised for issue by the Board on 29 September 2023.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements were prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland and the Companies Act 2006'.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Basis of consolidation

The consolidated financial statements consolidate the financial statements of the company and its subsidiary undertakings drawn up to 31 December 2022.

A subsidiary is an entity controlled by the company. Control is achieved where the company has the power to govern the financial and operating policies of an entity so as to obtain benefits from its activities.

The results of subsidiaries acquired or disposed of during the year are included in the Profit and Loss Account from the effective date of acquisition or up to the effective date of disposal, as appropriate. Where necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies into line with those used by the group.

The purchase method of accounting is used to account for business combinations that result in the acquisition of subsidiaries by the group. The cost of a business combination is measured as the fair value of the assets given, equity instruments issued and liabilities incurred or assumed at the date of exchange, plus costs directly attributable to the business combination. Identifiable assets acquired and liabilities and contingent liabilities assumed in a business combination are measured initially at their fair values at the acquisition date. Any excess of the cost of the business combination over the acquirer’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities recognised is recorded as goodwill.

Inter-company transactions, balances and unrealised gains on transactions between the company and its subsidiaries, which are related parties, are eliminated in full. Intra-group losses are also eliminated but may indicate an impairment that requires recognition in the consolidated financial statements.

Accounting policies of subsidiaries have been changed where necessary to ensure consistency with the policies adopted by the group.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

Going concern

Whilst the Group has been loss making throughout the period, due to the Group having net current assets, and successfully raising over £9.5m in equity funding in 2023, the Board are confident that the Group will be able to meet its liabilities as they fall due for a period of not less than 12 months from the signing of the Balance Sheet.

On this understanding, the financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

Revenue from the sale of goods is recognised when all the following conditions are met:
- The Group has transferred the significant risks and rewards of the ownership to the buyer;
- The Group retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
- The amount can be reliably measured;
- It is probable that the Group will receive the consideration due under the transaction; and

All revenue from contracts to provide services are recognised over the period in which the services are provided. This is to be recognised in line with the stage of completion as at the balance sheet date.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the group operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the consolidated financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Furniture, fittings and equipment

36 months straight line

Other plant and lab equipment

36 and 84 months straight line

Intangible assets

Separately acquired trademarks and licences are shown at historical cost.

Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date.

Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Trademarks and patents

120 months straight line

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Where the fair value of unlisted investments can be reliably measured, they are measured at fair value, with changes in fair value recognised in the profit and loss account.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the group will not be able to collect all amounts due according to the original terms of the receivables.

Debtors receivable within one year

Debtors with no stated interest rate and receivable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the group does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.


Creditors payable within one year

Creditors with no stated interest rate and payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.

Creditors due after more than one year

Creditors with no stated interest rate and payable after more than one year are recorded at transaction price as a non-current liability. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
 

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the group has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the group has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Share based payments

The cost and corresponding increase in equity in respect of equity-settled share-based payment transactions with employees are measured by references to the fair value of the equity instruments issued at the date of grant. Amounts are expensed on a straight line basis over the vesting period based on the estimate of shares that will eventually vest and adjusted for the effect of non-market based vesting conditions. The cost and fair value of the liability incurred in respect of cash-settled transactions is measured using an appropriate option pricing model with changes in fair value recognised in the profit and loss for the period.

3

Turnover

The analysis of the group's Turnover for the year from continuing operations is as follows:

2022
£

2021
£

Sale of goods

3,725,258

2,122,244

Grant income

393,118

61,435

4,118,376

2,183,679

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

4

Other operating income

The analysis of the group's other operating income for the year is as follows:

2022
£

2021
£

Government grants

-

8,731

Miscellaneous other operating income

-

1,727

-

10,458

5

Operating loss

Arrived at after charging/(crediting)

2022
£

2021
£

Depreciation expense

733,922

142,012

Amortisation expense

4,900

-

Research and development cost

133,142

5,909

6

Other interest receivable and similar income

2022
£

2021
£

Interest income on bank deposits

2,534

-

7

Interest payable and similar expenses

2022
£

2021
£

Interest on bank overdrafts and borrowings

5,023

8,731

Interest expense on other finance liabilities

60,000

-

Foreign exchange (losses)/gains

(28,962)

397

36,061

9,128

8

Staff costs

The aggregate payroll costs (including directors' remuneration) were as follows:

2022
£

2021
£

Wages and salaries

5,297,813

2,203,718

Social security costs

473,678

230,128

Other short-term employee benefits

2,911

645

Pension costs, defined contribution scheme

115,591

35,726

Other employee expense

183,967

213,479

6,073,960

2,683,696

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

The average number of persons employed by the group (including directors) during the year, analysed by category was as follows:

2022
No.

2021
No.

Production

51

28

Administration and support

10

8

Research and development

16

5

Sales, marketing and distribution

21

11

Other departments

9

4

107

56

9

Directors' remuneration

The directors' remuneration for the year was as follows:

2022
£

2021
£

Remuneration

300,000

228,380

Contributions paid to defined contribution schemes

3,963

3,957

303,963

232,337

During the year the number of directors who were receiving benefits and share incentives was as follows:

2022
No.

2021
No.

Received or were entitled to receive shares under long term incentive schemes

2

2

Accruing benefits under defined contribution pension scheme

3

3

10

Auditors' remuneration

2022
£

2021
£

Audit of these financial statements

8,500

6,000

Other fees to auditors

All other assurance services

3,700

4,360

All other non-audit services

8,503

6,655

12,203

11,015


 

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

11

Taxation

Tax charged/(credited) in the consolidated profit and loss account

2022
£

2021
£

Current taxation

UK corporation tax

(327,605)

(194,831)

Deferred taxation

Arising from origination and reversal of timing differences

(10,005)

-

Tax receipt in the income statement

(337,610)

(194,831)

The tax credit of £327,605 (2021: £194,831) relates to a Research & Development Tax Credit claim. Management considers the R&D claim to not only include direct consumables recorded as Research & Development costs in the Profit and loss but also a proportion of staff labour. In 2022, the amount of staff labour attributed to R&D was £810,706 (2021: £574,570).

12

Intangible assets

Group

Trademarks, patents and licenses
 £

Total
£

Cost or valuation

Additions acquired separately

70,801

70,801

At 31 December 2022

70,801

70,801

Amortisation

Amortisation charge

4,900

4,900

At 31 December 2022

4,900

4,900

Carrying amount

At 31 December 2022

65,901

65,901

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

Company

Trademarks, patents and licenses
 £

Total
£

Cost or valuation

Additions acquired separately

70,801

70,801

At 31 December 2022

70,801

70,801

Amortisation

Amortisation charge

4,900

4,900

At 31 December 2022

4,900

4,900

Carrying amount

At 31 December 2022

65,901

65,901

13

Tangible assets

Group

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 January 2022

1,064,074

745,583

1,809,657

Additions

1,522,721

571,297

2,094,018

At 31 December 2022

2,586,795

1,316,880

3,903,675

Depreciation

At 1 January 2022

91,422

237,109

328,531

Charge for the year

462,518

265,005

727,523

At 31 December 2022

553,940

502,114

1,056,054

Carrying amount

At 31 December 2022

2,032,855

814,766

2,847,621

At 31 December 2021

972,652

508,474

1,481,126

Assets held under finance lease or hire purchase

Total assets held under finance lease or hire purchase was £nil (2021: £nil)

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

Company

Furniture, fittings and equipment
 £

Other tangible assets
£

Total
£

Cost or valuation

At 1 January 2022

1,064,074

745,583

1,809,657

Additions

126,775

571,297

698,072

At 31 December 2022

1,190,849

1,316,880

2,507,729

Depreciation

At 1 January 2022

91,422

237,109

328,531

Charge for the year

180,064

265,005

445,069

At 31 December 2022

271,486

502,114

773,600

Carrying amount

At 31 December 2022

919,363

814,766

1,734,129

At 31 December 2021

972,652

508,474

1,481,126

Assets held under finance lease or hire purchase

Total assets held under finance lease or hire purchase was £nil (2021: £nil)

14

Investments

Company

2022
£

2021
£

Investments in subsidiaries

1

-

Subsidiaries

£

Cost or valuation

Additions

1

Provision

Carrying amount

At 31 December 2022

1

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

Details of undertakings

Details of the investments (including principal place of business of unincorporated entities) in which the company holds 20% or more of the nominal value of any class of share capital are as follows:

Undertaking

Registered office

Holding

Proportion of voting rights and shares held

     

2022

2021

Subsidiary undertakings

Nature Metrics North America Ltd

590 Hanlon Creek, Unit 11, Guelph, Ontario, N1C 0A1

Canada

Ordinary shares

100%

0%

Subsidiary undertakings

Nature Metrics North America Ltd

The principal activity of Nature Metrics North America Ltd is envinronmental consulting and biotechnology research and development..

15

Other financial assets

Group

Financial assets
£

Total
£

Non-current financial assets

Cost or valuation

At 1 January 2022

186,138

186,138

At 31 December 2022

186,138

186,138

Impairment

Carrying amount

At 31 December 2022

186,138

186,138

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

Company

Financial assets
£

Total
£

Non-current financial assets

Cost or valuation

At 1 January 2022

186,138

186,138

At 31 December 2022

186,138

186,138

Impairment

Carrying amount

At 31 December 2022

186,138

186,138

Financial assets represents a minority shareholding in NatureSpace Partnership Limited, a UK registered private limited company (registration no. 10755017).

16

Stocks

 

Group

Company

2022
£

2021
£

2022
£

2021
£

Inventory

428,084

336,650

397,264

336,650

17

Debtors

   

Group

Company

Current

Note

2022
£

2021
£

2022
£

2021
£

Trade debtors

 

812,197

720,874

741,254

720,874

Amounts owed by related parties

-

-

1,862,522

-

Other debtors

 

165,372

169,340

165,372

169,340

Prepayments

 

251,388

165,173

182,438

165,173

Accrued income

 

135,128

-

135,128

-

VAT amounts due

278,373

247,271

278,371

247,271

Income tax asset

11

517,255

185,657

517,255

185,657

   

2,159,713

1,488,315

3,882,340

1,488,315

Held within the other debtors balance of £165,372 is a rental deposit totalling £159,371. Per the rental agremeent, the rental agreement expires in 2031 with a break clause available to the Company in 2026. Therefore, the debtor balance of £159,371 is not recoverable until this point and is deemed a debtor due after one year.

18

Cash and cash equivalents

 

Group

Company

2022
£

2021
£

2022
£

2021
£

Cash at bank

6,540,255

3,742,361

6,471,594

3,742,361

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

19

Creditors

   

Group

Company

Note

2022
£

2021
£

2022
£

2021
£

Due within one year

 

Loans and borrowings

20

43,862

43,862

43,862

43,862

Trade creditors

 

1,038,340

913,778

975,396

913,778

Social security and other taxes

 

187,772

105,809

174,826

105,809

Outstanding defined contribution pension costs

 

97,271

12,136

97,271

12,136

Other payables

 

7,238

15,987

7,237

15,987

Accruals

 

313,580

127,346

313,580

127,346

Amounts relating to Occam Court

 

343,919

300,000

343,919

300,000

Deferred income

 

815,131

605,753

720,810

605,753

 

2,847,113

2,124,671

2,676,901

2,124,671

Due after one year

 

Loans and borrowings

20

7,310

51,173

7,310

51,173

20

Loans and borrowings

 

Group

Company

2022
£

2021
£

2022
£

2021
£

Non-current loans and borrowings

Bank borrowings

7,310

51,173

7,310

51,173

 

Group

Company

2022
£

2021
£

2022
£

2021
£

Current loans and borrowings

Bank borrowings

43,862

43,862

43,862

43,862

Bank borrowings of £51,172 (£43,862 due within 1 year, £7,310 due after 1 year) at 31 December 2022 represents an unsecured loan obtained through the Coronavirus Business Interruption Loan Scheme (CBILS), incurring interest of 14.03% per annum. The loan is due to be repaid in full by February 2024.

 

Nature Metrics Limited

Notes to the Financial Statements for the Year Ended 31 December 2022

21

Pension and other schemes

Defined contribution pension scheme

The group operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the group to the scheme and amounted to £115,591 (2021 - £35,726).

Contributions totalling £97,271 (2021 - £12,136) were payable to the scheme at the end of the year and are included in creditors.

22

Share capital

Allotted, called up and fully paid shares

 

2022

2021

 

No.

£

No.

£

Ordinary shares of £0.00 each

1,943,115

2

2,366,400

2

Series A shares of £0.00 each

901,121

1

1,190,476

1

Series A-1 shares of £0.00 (2021 - £0) each

2,366,988

2

-

-

 

5,211,224

5

3,556,876

4

During the year 1,647,444 Series A-1 shares having an aggregate nominal value of £1.647 were allotted for an aggregate consideration of £11,999,982. 6,904 Ordinary shares having an aggregate nominal value of £0.007 were also allotted for an aggregate consideration of £21,882.

In addition, there were various redesignations of share classes in the year; 303,218 Series A shares were redesignated as 303,218 Series A-1 shares, 13,863 Ordinary shares were redesignated as 13,863 Series A shares and 416,326 Ordinary shares were redesignated as 416,326 Series A-1 shares.

23

Non adjusting events after the financial period

Resignation of CEO
In July 2023, Katie Critchlow formally resigned as CEO of the Company. We do not expect this to have an impact on the financial statements.

Fundraising secured
In July 2023, the Company secured equity fundraising of approximately £9,499,997. While this does not have an impact on the financial position of the Company as at the Balance Sheet date, it does significantly strengthen the financial position of the Company in 2023 and provide added assurance to the Going Concern of the Company for the 12 months from the signing date of the Balance Sheet.